- Stocks Telegraph Morning
- Posts
- 06 Mar - NH - Morning Newsletter (with survey at top and bottom)
06 Mar - NH - Morning Newsletter (with survey at top and bottom)
Today's Market Buzz: Get the Inside Scoop
The Newsheater daily morning newsletter is powered by Stocks Telegraph
Help us improve newsletter by taking
Good Morning!According to the trading data on Monday, US stock indices are generally stable. It will be interesting to see what US Federal Reserve Chairman Jerome Powell has to say to Congress later in the week.Futures for the Dow Jones Industrial Index (DJIA) decreased by 0.04%, to 33,400 points. Futures for the NASDAQ high-tech companies index grew by 0.08%, to 12,321.5 points and futures for the broad market index S&P 500 increased by 0.01% to 4,050.25 points.A major event of the week is the upcoming speech by Jerome Powell, chairman of the American central bank. A speech by the head of the Fed will be given on Tuesday to the banking committee, and on Wednesday to the financial services committee.With inflation and recession risks still high, investors are paying close attention to Powell for clues about the Fed's interest rate plans. In particular, they are looking for clues about the end of the Fed's hike cycle.
Free Report: Elon Musk Reveals Secret Master Plan 3.0
Inside you'll discover how you could have earned 1,766% - 24,017% profits investing after he released Master Plan Part 1 & 2. Now it's your chance to discover the best stocks to buy RIGHT NOW.
Sponsored
Today Top Movers
TCR2 Therapeutics Inc. (TCRR) stock soared 42.15% to $1.72 in the pre-market trading after announcing a definitive agreement with Adaptimmune Therapeutics plc (ADAP), under which Adaptimmune will combine with TCR² in an all-stock transaction to create a preeminent cell therapy company focused on treating solid tumors.
Kala Pharmaceuticals Inc. (NASDAQ: KALA) shares are trading up 23.88% at $20.75 at the time of writing. The company recently reported financial results for the fourth quarter and full year ended December 31, 2022.
Azul S.A. (AZUL) grew over 20.67% at $5.02 in pre-market trading today after annooucing agreements with aircraft lessors responsible for 90% of its obligations that would give them equity and tradeable debt in exchange for lower payments.
Nyxoah S.A. (NYXH), a Medical Instruments & Supplies company, rose about 19.73% at $6.13 in pre-market trading Monday after announcing that it has completed all 115 implants in its DREAM U.S. pivotal study, submitted the first module in the modular PMA submission and implanted the first patient in the ACCCESS U.S. pivotal study.
Top 7 Energy Stocks for 2023
Louis Navellier aka the "King of Quants" just isolated the top 7 energy stocks in 2023 with the help of his propriety system. It's the same system that helped Louis find 676 triple digit winners... 141 gains over 1,000%... and 21 gains soaring 10,000% in his 40 years career. With so much uncertainty from our government and media... Louis trusted algorithm can be your guide towards potential earnings.
Sponsored
Top Upgrades & Downgrades
JP Morgan turned bullish on Vir Biotechnology Inc. (VIR), upgrading the stock to Overweight and assigning a $34 price target, representing potential upside of 48.86% from Friday's close.
REV Group Inc. (REVG) has won the favor of Baird's equity research team. The firm upgraded the shares from Neutral to Outperform and moved their price target to $16, suggesting 32.67% additional upside for the stock.
HashiCorp Inc. (HCP) received an upgrade from analysts at Needham, who also set their one-year price target on the stock to $39. They changed their rating on HCP to Buy from Hold in a recently issued research note.
Earlier Monday JP Morgan reduced its rating on D.R. Horton Inc. (DHI) stock to Neutral from Overweight and assigned the price target to $102.5.
JP Morgan analysts reduced their investment ratings, saying in research reports covered by the media that its rating for KB Home (KBH) has been changed to Underweight from Overweight and the new price target is set at $32.5.
Analysts at Deutsche Bank downgraded Euronav NV (EURN)'s stock to Hold from Buy Monday.
Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Sponsored
Latest Insider Activity
Permian Resources Corporation (PR) EVP, Chief Operating Officer Garrison Matthew R. announced the sale of shares taking place on Mar 03 at $12.00 for some 40,000 shares. The total came to more than $0.48 million.
Hims & Hers Health Inc. (HIMS) Director Bard Alex sold on Mar 02 a total 2,319,109 shares at $10.78 on average. The insider’s sale generated proceeds of almost $25.0 million.
American Homes 4 Rent (AMH) Director BENHAM DOUGLAS N declared the purchase of shares taking place on Mar 03 at $23.85 for some 3,725 shares. The transaction amount was around $88835.0.
Akamai Technologies Inc. (AKAM) Chief Executive Officer LEIGHTON F THOMSON bought on Mar 03 a total 338 shares at $74.17 on average. The purchase cost the insider an estimated $25,069.
How To Identify Undervalued Stocks BEFORE They Rise In Value…
Trading expert and author Thomas Wood has finally released his highly anticipated guide, "The Easy Way To Find Undervalued Stocks" and right now, you can download it for free! Don't let the chance to learn to trade like Warren Buffett slip away…
Sponsored
Important Earnings
Top US earnings releases scheduled for today include Lordstown Motors Corp. (NASDAQ: RIDE). It will announce its Dec 2022 financial results. The company is expected to report earnings of -$0.27 per share from revenues of $1.29M in the three-month period.
Analysts expect Ciena Corporation (NYSE: CIEN) to report a net income (adjusted) of $0.36 per share, when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended Jan 2023 is predicted to come in at $959.4M.
Azul S.A. (AZUL), due to announce earnings before the market opens today, is expected to report earnings of -$0.47 per share from revenues of $895.55M recently concluded three-month period.
That's it for today. Thanks for reading. Good luck out there!Best Regards,Stocks Telegraph Team
P.S. Want my daily watchlists sent to your cell phone too? Just go HERE and join my text message list!
Wouldn’t it be great to have a personalized solution for your investing needs? We’re adding new sections to the morning newsletter with big implications. All you have to do is share your thought about the current newsletter. If you do that, we’ll do our best to take your feedback and make it a better experience for you.
We are asking for 1 minute of your time to answer 4 questions about your experience with our newsletter. We hope to use this information to create solutions that address exactly what you need!
Thank you for your continued support.
Disclaimer: Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails.